Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-29,900
Closed -$1.77M 5602
2021
Q4
$1.77M Sell
29,900
-10,000
-25% -$692K ﹤0.01% 3464
2021
Q3
$2.65M Sell
39,900
-10,000
-20% -$617K ﹤0.01% 2752
2021
Q2
$3.15M Buy
49,900
+29,900
+150% +$1.68M ﹤0.01% 2473
2021
Q1
$1.04M Buy
+20,000
New +$1.22M ﹤0.01% 3081

Other funds holding CYRX

David Shaw's CYRX Position: Q2 2026 in Review

David Shaw increased its CryoPort (CYRX) stake by 203% in Q2 2026, buying an estimated $4.12M and bringing the position to 479,625 shares worth $7.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2076.

David Shaw first reported a position in CYRX in Q3 2018 and has held it in 25 quarters since. The position peaked at $19.5M in Q3 2020. 185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • David Shaw held 479,625 shares of CryoPort worth $7.53M as of Q2 2026.
  • David Shaw bought 321,400 CryoPort shares in Q2 2026, an estimated $4.12M.
  • CryoPort made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2076 holding.
  • David Shaw first reported a position in CryoPort in Q3 2018 and has held it in 25 quarters since.
  • David Shaw's CryoPort position peaked at $19.5M in Q3 2020.
  • 185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.